{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:00Z","timestamp":1790700180372,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1029467"],"award-info":[{"award-number":["1029467"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jcyt.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T10:57:59Z","timestamp":1446807479000},"page":"65-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells"],"prefix":"10.1016","volume":"18","author":[{"given":"Shivashni S.","family":"Deo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Virassamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieland","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania C.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcyt.2015.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ejca.2005.03.007","article-title":"Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution","volume":"41","author":"Castagnola","year":"2005","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jcyt.2015.09.013_bib0015","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jcyt.2015.09.013_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2009.08072.x","article-title":"Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant","volume":"149","author":"Hale","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2015.09.013_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2141.2005.05887.x","article-title":"Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia","volume":"132","author":"Halliday","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jcyt.2015.09.013_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-3062.2002.00010.x","article-title":"Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients","volume":"4","author":"De La Rosa","year":"2002","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.jcyt.2015.09.013_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jcyt.2015.09.013_bib0040","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jcyt.2015.09.013_bib0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jcyt.2015.09.013_bib0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jcyt.2015.09.013_bib0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/40.3.401","article-title":"Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection","volume":"40","author":"Denning","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.jcyt.2015.09.013_bib0060","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/clinids\/22.Supplement_2.S112","article-title":"The new fungal opportunists are coming","volume":"22","author":"Perfect","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcyt.2015.09.013_bib0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1348-0421.1999.tb01231.x","article-title":"Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus","volume":"43","author":"Seo","year":"1999","journal-title":"Microbiol Immunol"},{"issue":"7","key":"10.1016\/j.jcyt.2015.09.013_bib0070","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.37.7.2343-2345.1999","article-title":"In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole","volume":"37","author":"Sutton","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jcyt.2015.09.013_bib0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/649879","article-title":"Fungal infections in leukemia patients: how do we prevent and treat them?","volume":"50","author":"Leventakos","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jcyt.2015.09.013_bib0080","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jcyt.2015.09.013_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.1999.tb01120.x","article-title":"Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes","volume":"63","author":"Pagano","year":"1999","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2015.09.013_bib0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.medmal.2013.02.010","article-title":"Azole resistant Aspergillus fumigatus: an emerging problem","volume":"43","author":"Lelievre","year":"2013","journal-title":"Med Mal Infect"},{"issue":"6","key":"10.1016\/j.jcyt.2015.09.013_bib0095","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.jcyt.2015.09.013_bib0100","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/IAI.66.12.5999-6003.1998","article-title":"Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus","volume":"66","author":"Roilides","year":"1998","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.jcyt.2015.09.013_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2008.02.014","article-title":"Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood","volume":"335","author":"Beck","year":"2008","journal-title":"J Immunol Methods"},{"issue":"13","key":"10.1016\/j.jcyt.2015.09.013_bib0110","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2015.09.013_bib0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3109\/14653249.2012.704013","article-title":"Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus","volume":"14","author":"Gaundar","year":"2012","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2015.09.013_bib0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2010.03383.x","article-title":"Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides","volume":"132","author":"Wang","year":"2011","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.jcyt.2015.09.013_bib0125","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/bp070334t","article-title":"Quantifying metabolic activity of filamentous fungi using a colorimetric XTT assay","volume":"24","author":"Moss","year":"2008","journal-title":"Biotechnol Prog"},{"issue":"6","key":"10.1016\/j.jcyt.2015.09.013_bib0130","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","article-title":"Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus","volume":"107","author":"Beck","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2015.09.013_bib0135","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1128\/IAI.71.11.6472-6478.2003","article-title":"Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury","volume":"71","author":"Gil-Lamaignere","year":"2003","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.jcyt.2015.09.013_bib0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcyt.2012.11.014","article-title":"Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes","volume":"15","author":"Tramsen","year":"2013","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.jcyt.2015.09.013_bib0145","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.4049\/jimmunol.1400776","article-title":"Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells","volume":"193","author":"Bacher","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2015.09.013_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2008.271","article-title":"Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy","volume":"43","author":"Tramsen","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2015.09.013_bib0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbmt.2013.01.021","volume":"19","author":"Clancy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"10.1016\/j.jcyt.2015.09.013_bib0160","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jcyt.2015.09.013_bib0165","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2015.09.013_bib0170","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2010-12-322610","article-title":"Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154","volume":"118","author":"Khanna","year":"2011","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915010749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915010749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:22:30Z","timestamp":1761430950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915010749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1465324915010749"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.09.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}